Description: The cell and gene therapy marketplace is quickly evolving and continues to grow as a risk concern for governments, health plans, stop loss insurers and reinsurers. In this webinar, we discuss currently approved tissue, cell and gene therapies, the near-term pipeline, uptake considerations, case management processes, plan document and contract considerations, risk mitigation processes and programs, and network considerations.

Description: CMS has pioneered innovative strategies for Medicare and Medicaid to address Social Determinants of Health (SDOH). Employers can learn from these models to implement similar approaches for their employee populations. Learn how employers can understand and address SDOH, the incentives for doing so, and the broader benefits.

Description: This session will delve into the results of a recent industry study exploring dynamic lapse behavior over the past five years in U.S. insurance products with general account credited rate-type features.

Description: The health insurance industry has historically used several factors to develop premium rates. Many of these, e.g. gender rating, have been largely eliminated from health insurance rating practices by regulations as the Patient Protection and Affordable Care Act (ACA) because they were determined as inequitable. However, several other factors still remain as differentiators in premium rates charged to individuals and groups. In conjunction with the SOA, researchers studied whether there could be ‘ghost’ rating factors, like race, ethnicity, or socioeconomic status, that are inherently included in some of these remaining allowable factors. Review results and opportunities for future research. By attending this webcast, you will be challenged to think about traditional rating factors in a different way. Rather than focusing on whether certain factors are sound based on the underlying claims cost, this session will focus on whether or not these factors are impacting certain socioeconomic or racial/ethnic groups disparately.

Description: Learn more about Health Care Sharing Ministries (HCSMs) and their functionality as health insurance. These nonprofit companies pool money from participating members to assist with members' healthcare coverage. Further exploring HCSMs, some of the offered arrangements of this plan operate differently and with a unique regulatory framework. HCSM enrollment has grown 1000% since solidification as a law in the ACA. By signing up for this webcast, you can discover why HCSMs are becoming a key component of the individual market in some states.

Description: ReMark's Global Consumer Study delivers 10 key insights to empower customers. Insurers can design products that meet customers' needs and enhance client experiences and add significant value to their business. At the same time with new products being launched seemingly continuously, it is important to take a step back and assess risk throughout the product management cycle.

Description: In discussing the contemporary reactions to this regulation, as well as how EU-based insurance firms adapted to the shift, this segment will invite us to question our assumptions on the role of gender-based pricing in the future of the industry. In the latter half of the presentation, we will delve into the challenges faced by LGBTQ+ individuals when accessing life, health, and auto insurance.

Description: A comprehensive webcast designed to bring together industry practitioners to discuss the current state of Model Risk Management (MRM) frameworks. This event will delve into the advancements in MRM, the challenges faced by professionals in the field, and emerging trends such as machine learning model validation that are set to shape the future of MRM. Engage with experts, share knowledge, and explore innovative solutions to enhance the effectiveness of your MRM framework.

Description: This session will address the risk management, reserving and capital issues associated with index-linked annuities including financial reporting considerations for FIAs and RILAs, benefits of combining VA and RILA hedging and reserving under VM-21, current and future challenges with FIA reserving under VM-22, potential capital redundancy for FIAs, RILA interim values under AG 54, NAIC economic scenario reform, asset modeling, fund mapping and more!

Description: Understanding how to effectively adopt AI is critical to staying competitive. This session will guide you through the five stages of AI adoption, with a deep dive into two key stages: Operational Optimization and Collaborative AI Integration. You will learn how to harness AI to streamline operations and boost efficiency, while also exploring the nuances of integrating AI in decision-making to enhance outcomes through human-AI collaboration.If you are seeking practical insights on maximizing AI's benefits while maintaining human oversight, this session will provide the tools and strategies to help you do just that—ensuring that your AI adoption journey is both effective and aligned with your business goals.